NCT04316026

Brief Summary

Introduction: Shock wave therapy (SWT) has a potential interest to treat spasticity. However, the pathophysiology of this treatment remains unknown. Some authors assert that it is effective on spasticity itself, while others suggest that it acts more on fibrosis. Method: this study will assess the effectiveness of radial SWT to treat wrist and finger flexors stiffness in stroke patients, comparing subacute spastic patients (\< 12 months) with chronic patients presenting muscle contractures (\> 12 months). Forty-eight stroke patients (24 in the subacute phase and 24 in the chronic phase) will be included. One real and one sham sessions of SWT will be performed with a 2-week interval. The order of the sessions will be randomized. Motor control, stiffness and spasticity will be assessed with clinical and objective measures, just after and just before each session, by a blind assessor. The targeted muscles will be flexor carpi radialis, flexor carpi ulnaris and flexor digitorum profundus, and will be the same for the two session.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 20, 2020

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

April 13, 2023

Status Verified

April 1, 2023

Enrollment Period

4.2 years

First QC Date

January 7, 2020

Last Update Submit

April 12, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Modified Ashworth Scale

    Clinical assessment of spasticity for wrist and fingers flexors, score from 0 to 4 (a higher score representing a greater spasticity)

    Before (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)

  • Tardieu scale

    Clinical assessment of spasticity for wrist and fingers flexors; score from 0 to 4 (a higher score representing a greater spasticity)

    Before (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)

Secondary Outcomes (11)

  • objective measure of elastic and viscous stiffness of the wrist, expressed in N.m.rad

    Before (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)

  • objective measure of muscle stiffness

    Before (baseline) and 10 minutes (post-treatment) after each of the two sessions (sham or real SWT)

  • manual goniometer

    Before (baseline) and 10 minutes (post-treatment) after each of the two sessions (sham or real SWT)

  • Medical Research Council muscle testing

    Before (baseline) and 25 minutes (post-treatment) after each of the two sessions (sham or real SWT)

  • Isokinetic dynamometer

    Before (baseline) and 15 minutes (post-treatment) after each of the two sessions (sham or real SWT)

  • +6 more secondary outcomes

Study Arms (2)

interventional group

EXPERIMENTAL

group receiving shock wave therapy

Device: shock wave therapy

control group

SHAM COMPARATOR

sham shock wave therapy

Device: shock wave therapy

Interventions

Shockwave therapy is a non-invasive treatment creating a series of low energy acoustic wave pulsations that are directly applied through the skin via a gel medium

control groupinterventional group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of cerebral lesion
  • Wrist spasticity ≥ 1+/4 on the Modified Ashworth Scale
  • Wrist spasticity ≥ 2/4 on the Tardieu Scale
  • Passive dorsal extension of the wrist ≥ 10°

You may not qualify if:

  • Botulinum toxin injection in the upper limb in the past three months
  • History of wrist arthrodesis
  • Myopathy
  • Treatment with oral anticoagulants or coagulation disease
  • Tumor or infection of the paretic upper limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques universitaires Saint-Luc

Brussels, 1200, Belgium

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Gaëtan Stoquart, MD, PhD

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gaëtan Stoquart, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2020

First Posted

March 20, 2020

Study Start

September 2, 2019

Primary Completion

December 1, 2023

Study Completion

June 1, 2024

Last Updated

April 13, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations